A 50-Year-Old Man with Deteriorating Cognitive Function and Impaired Movement
article has not abstract
Vyšlo v časopise:
A 50-Year-Old Man with Deteriorating Cognitive Function and Impaired Movement. PLoS Med 6(1): e19. doi:10.1371/journal.pmed.1000019
Kategorie:
Learning Forum
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1000019
Souhrn
article has not abstract
Zdroje
1. American Psychiatric Association
2000
Diagnostic and statistical manual of mental disorders
4th edition
text revision (DSM-IV-TR)
Washington (D. C.)
American Psychiatric Association
943
2. DoranM
1997
Diagnosis of presenile dementia.
Br J Hosp Med
58
105
110
3. MendezMF
2006
The accurate diagnosis of early-onset dementia.
Int J Psychiatry Med
36
401
412
4. RatnavalliEBrayneCDawsonKHodgesJR
2002
The prevalence of frontotemporal dementia.
Neurology
58
1615
1621
5. HodgesJR
editor
2007
Frontotemporal dementia syndromes
Cambridge (UK)
Cambridge University Press
346
6. VarmaARSnowdenJSLloydJJTalbotPRMannDM
1999
Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer's disease and frontotemporal dementia.
J Neurol Neurosurg Psychiatry
66
184
188
7. LarnerAJ
2008
Neuropsychological neurology: The neurocognitive impairments of neurological disorders
Cambridge (UK)
Cambridge University Press
248
8. McKhannGDrachmanDFolsteinMKatzmanRPriceD
1984
Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Service Task forces on Alzheimer's disease.
Neurology
34
939
944
9. CrutsMvan DuijnCMBackhovensHVan den BroeckMWehnertA
1998
Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease.
Hum Mol Genet
7
43
51
10. GauthierSEmreMFarlowMRBullockRGrossbergGT
2003
Strategies for continued successful treatment of Alzheimer's disease: Switching cholinesterase inhibitors.
Curr Med Res Opin
19
707
714
11. LitvanIAgidYCalneDCampbellGDuboisB
1996
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP international workshop.
Neurology
47
1
9
12. FosterNLWilhelmsenKSimaAAJonesMZD'AmatoCJ
1997
Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference.
Ann Neurol
41
706
715
13. Johns Hopkins University
2008
Online Mendelian inheritance in man.
Available: http://www.ncbi.nlm.nih.gov/sites/entrez?db=omim. Accessed 15 December 2008
14. BakTHHodgesJR
1998
The neuropsychology of progressive supranuclear palsy.
Neurocase
4
89
98
15. TsuboiYJosephsKACooksonNDicksonDW
2003
APOE E4 is a determinant for Alzheimer type pathology in progressive supranuclear palsy.
Neurology
60
240
245
16. UrasakiKKurikiKNamerikawaMSatohSIkeguchiK
2000
An autopsy case of Alzheimer's disease with a progressive supranuclear palsy overlap.
Neuropathology
20
233
238
17. KasahataNAraiNMakitaY
2008
An Alzheimer disease with dementia with Lewy bodies patient presenting progressive supranuclear palsy-like clinical manifestations and radiological atrophy of midbrain tegmentum. A clinical and neuropathological study.
J Neurol
255
Suppl 2
196
18. BoeveBFDicksonDDuffyJBartlesonJTrenerryM
2003
Progressive nonfluent aphasia and subsequent aphasic dementia associated with atypical progressive supranuclear palsy pathology.
Eur Neurol
49
72
78
19. MochizukiAUedaYKomatsuzakiYTsuchiyaKAraiT
2003
Progressive supranuclear palsy presenting with primary progressive aphasia—Clinicopathological report of an autopsy case.
Acta Neuropathol
105
610
614
20. University of Antwerp Molecular Genetics Department
2008
Alzheimer disease and frontotemporal dementia mutation database.
Available: http://www.molgen.ua.ac.be/Admutations/. Accessed 15 December 2008
21. DoranMdu PlessisDGGhadialiEJMannDMAPickering-BrownS
2007
Familial early-onset dementia with tau intron 10 +16 mutation with clinical features similar to those of Alzheimer disease.
Arch Neurol
64
1535
1539
22. LarnerAJ
2008
Mutation negative “early-onset familial Alzheimer's disease”: Consider screening for tau gene mutations.
Alzheimer Dis Assoc Disord
22
194
195
23. MorrisHROsakiYHoltonJLeesAJWoodNW
2003
Tau exon 10 +16 mutation FTDP-17 presenting clinically as sporadic young onset PSP.
Neurology
61
102
104
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2009 Číslo 1
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Co dělat při intoleranci statinů?
- Pleiotropní účinky statinů na kardiovaskulární systém
- DESATORO PRE PRAX: Aktuálne odporúčanie ESPEN pre nutričný manažment u pacientov s COVID-19
Najčítanejšie v tomto čísle
- Rape in War Is Common, Devastating, and Too Often Ignored
- Improving Maternal and Child Health in Difficult Environments: The Case For “Cross-Border” Health Care
- Time To Move from Presumptive Malaria Treatment to Laboratory-Confirmed Diagnosis and Treatment in African Children with Fever
- The Role of Social Capital in Successful Adherence to Antiretroviral Therapy in Africa